Makers of medical devices that quickly measure oxygen levels in the blood would have to gather extra data to show that their ...
UW Medicine is unveiling an FDA-approved spinal cord therapy in an effort to offer new hope for paralyzed patients.
The regulator conducted a postmarketing trial which suggested increased risk of Guillain-Barré syndrome (GBS) 42 days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback